Faster drug reviews urged to fight obesity
Mark McClellan, commissioner of the U.S. Food and Drug Administration, said he wants to apply a fast-track review process, normally reserved for drugs for terminal cancer and AIDS patients, to drugs
Mark McClellan, commissioner of the U.S. Food and Drug Administration, said he wants to apply a fast-track review process, normally reserved for drugs for terminal cancer and AIDS patients, to drugs